MacLennan Selected Risks and Benefits after 5 Years of combined estrogen and progestogen HRT for all women aged 50-79 (WHI Study, 2002) OESTROGEN WITH.

Slides:

Advertisements

Similar presentations

Menopause in Women With IBD. Menopause Natural menopause results from gradual decline in number of estradiol-producing ovarian follicles Natural menopause.

Advertisements

Back to the Future: Applying New Evidence in Menopause Management

The health risks of artificial feeding of infants in the industrialized world are now (1)________. Breastfed infants receive protection (2)_________many.

1 Hormone Replacement Therapy (HRT). 2 Recent MHRA/CHM advice Drug Safety Update 2007; 1(2):2-4 The decision to prescribe HRT should be based on a thorough.

for Bio-Identical Hormones

Your Institution Here Your Institution Here Cardiovascular Disease in Women: Update on Menopausal Hormone Therapy and Selective Estrogen Receptor Modulators.

Menopause Lisa Keller, M.D.. Menopause Basics By 2010, 45% of American women will be over age 50.

Women’s Health Initiative - Summary of results DISCLAIMER Menopausetoday gives the following presentation for your information and.

Breast cancer chemoprevention in the high-risk patient

Harry Burns and Andrew Murray Scotland`s Health – Lessons learned from running to the Sahara Dundee Social Enterprise Conference October

 Heart disease is women’s No. 1 killer  Stroke is women’s No. 3 killer.

What women can do to stay healthy Valerie Beral University of Oxford THE MILLION WOMEN STUDY.

IS HRT SAFE? Rosol Hamid Consultant O&G. NO What is safe? Driving Swimming Crossing the street Cycling Riding a motor bike Parachute jumping Flying.

Breast Cancer Awareness October is Breast Cancer Awareness Month Submitted by Kadee Brousseau, Peer Advisor, University of Missouri.

Journal Club 12/02 Dr Stephen Newell. Current Problems in Pharmacovigilance October 2002 Safety update on long-term HRT.

Cardiovascular Disease in Women Module VI: Update on Menopausal Hormone Therapy and Selective Estrogen Receptor Modulators (SERMs)

Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.

Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy The Women’s Health Initiative Randomized Controlled Trial JAMA 2004;291:

Treatment. Bisphosphonates Promotes bone formation and decreases bone resorption Mechanism of Action First line treatment for osteoporosis in both men.

Healthy Living Factors in Preventing Serious Disease ( Diabetes, Cancer Heart Attack, Stroke)

A Colonscope is used to remove or biopsy polyps  Night Prep.

Long-Term Effects of Continuing Adjuvant Tamoxifen to 10 Years versus Stopping at 5 Years After Diagnosis of Oestrogen Receptor- Positive Breast Cancer:

JANET P. PREGLER, MD; CAROLYN J. CRANDALL, MD, MS. ANNALS OF INTERNAL MEDICINE. 2011; 155: JULIANNA L. MURPHY PHARM.D. CANDIDATE PRECEPTOR: ALI RAHIMI,

Better Health. No Hassles. Megan McCarren and Valerie Hacker Pacific Lutheran University November 2007 Women and Heart Disease.

Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.

Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.

Ovarian Cancer Research in Allied Health Erin Brewer.

1 Study of Tamoxifen and Raloxifene STAR Larry Wickerham, MD NSABP STAR Project Officer.

Canadian Cardiovascular Outcomes Research Team A Canadian Institutes of Health Research - Heart and Stroke Foundation of Canada Interdisciplinary.

Buckinghamshire County Council What’s the story ? Dr. Jane O’Grady Director of Public Health Buckinghamshire Buckinghamshire County Council.

5 Most Common Cancers. 1 in 2 men and 1 in 3 women in Australia will be diagnosed with cancer before the age of 85.

Slide Source: Lipids Online Slide Library Women’s Health Initiative: Trial of Estrogen plus Progestin 16,608 women randomized 16,608.

JOCELYNE MARTINEZ Osteoporosis. OSTEOPOROSIS – CAUSES BONES TO BECOME WEAK AND BRITTLE. What is it ?

Women’s Health Initiative: HRT Trial Baseline Data and Update on Follow-up Marcia L. Stefanick, Ph.D. Associate Professor of Medicine and of Obstetrics.

Medication Options H ealthPLACE/HOPE Program COPYRIGHT © 2002 Highmark Inc. All Rights Reserved. These materials may not be copied or otherwise reproduced.

How to survive your menopause David Griffiths Consultant Gynaecologist Christine Pearce Consultant Nurse 3 rd Sept 2014.

Breast Cancer Risk with Menopausal Hormone Use Jackie Bouillon Advisor: Dr. Robert Hadley Spring 2007.

Patterns of contraception in IDDM in the UK RA Lawrenson, GM Leydon, TJ Williams, RB Newson, MD Feher* Department of Epidemiology and Public Health, *Department.

FDA Presentation ODAC Meeting July NDA Applicant: Eli Lilly Evista ® (Raloxifene Hydrochloride)

WHI CT Sample Size, Outcomes, Follow-up Women, aged Total CT = 68,133 Diet Modification (DM) Trial Primary Outcomes: Breast & Colorectal Cancer Secondary.

Endometrial Cancer By Jessica Hall. Symptoms Unusual vaginal bleeding or discharge Difficult or painful urination Pain during intercourse Pain in the.

Updated 7/2015 AGENDA Susan G. Komen ® Introduction Local Organization/Komen Affiliate information Breast cancer information –Breast cancer statistics.

Hormone replacement therapy: practical considerations Marco Gambacciani and Nick Panay.

MENAPOUSE. Natural Surgical premature RETROSPECTIVE Cessation of menstruation for 12 months In the absence of other physiological or psychological.

Menopausal Hormone Replacement Professor Gordana Prelevic, MD, DSc, FRCP Consultant Endocrinologist Royal Free Hampstead NHS Trust Whittington Health.

KEEPING YOUR BODY FIT AND STRONG Karen Cradock, B.Physio, MSc.

STAR. 2 NSABP P-1 Trial Results: Age > 50 Category TamoxifenPlacebo ARD RR(95% CI) n 4010 IR n 4008 IR Breast Cancer Invasive Invasive Non-invasive Non-invasive

Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.

What does it mean to age? Deterioration over time! This can include; weakness, susceptibility to disease, loss of mobility and agility. The reduced ability.

50 Shades of Pink From your Oxford Centric team. Mississippi: Now and Beyond.

Breast cancer facts Daniela Cazares. Fact #1 In the US, 1 in 8 women will be diagnosed with breast cancer in their lifetime.

1 Risk Benefit and Conclusions George Sledge, MD Indiana University School of Medicine.

SC300 Unit five Prof. Maureen Foley AIM: FoleyMaur.

Diabetes: 0–44 years Ranked comorbidity combinations Source: ABS Australian Health Survey 2011–12 (National Health Survey component) For people aged 0–44,

M E N O P A U S E King Khalid University Hospital Department of Obstetrics & Gynecology Course 482.

Date of download: 6/27/2016 From: Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer Ann Intern Med.

Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.

SERMs Dr Sarvesh Singh Associate Professor

Menopause Paul Beck, MD, FACOG, FACS.

The Rise and Fall of Hormone Replacement Therapy

Exercise and Physical Activity

Impact of Oestrogen Therapy on Diabetes and Vascular Risk

9/18/2018 OSTEOPOROSIS.

Incidence rates for the three common osteoporotic fractures

Osteoporosis Definition

سرطان الثدي Breast Cancer

Figure 1 Adverse effects in women treated with HRT

The 9 Risk Factors and how important are they to your level of health?

The Research Question RESEARCH METHOD

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Presentation transcript:

MacLennan Selected Risks and Benefits after 5 Years of combined estrogen and progestogen HRT for all women aged (WHI Study, 2002) OESTROGEN WITH PROGESTOGEN Breast Cancers 8 Pulmonary Embolism 8 Bowel and Uterine Cancers 10 Fractures Hip and Spine 10,000 Women Years Increase Decrease Stroke 8 CVD* 7 * Not statistically significant

MacLennan Selected Risks and Benefits after 7 Years of estrogen only HRT for all women aged (WHI Study, 2004) OESTROGEN ONLY 8 Breast Cancers* Pulmonary embolism* 3 5 CVD* 12 Fractures Hip and Spine 10,000 Women Years Increase Decrease Stroke 12 * Not statistically significant Bowel Cancer* 1

MacLennan Combined Estrogen + Progestogen HRT outcomes when initiated under age 60. (Data from 5,522 women in WHI Study) Breast Cancer 2 Pulmonary Embolism 1 Stroke 4 10,000 Women Years Increase Decrease CVD 7 Deaths 13 Diabetes 56 All Fractures ESTROGEN AND PROGESTOGEN

MacLennan Estrogen only HRT outcomes when initiated under age 60 (Data from 3,310 women in WHI Study) 8 Breast Cancer Pulmonary Embolism 1 2 Stroke 56 All Fractures 10,000 Women Years Increase Decrease 11 CVD 3 Total Deaths Diabetes ESTROGEN ONLY